Obesity and Cardiometabolic Risk Factors in Children and Young Adults With Non-classical 21-Hydroxylase Deficiency

被引:15
作者
de Vries, Liat [1 ,2 ]
Lebenthal, Yael [1 ,2 ]
Phillip, Moshe [1 ,2 ]
Shalitin, Shlomit [1 ,2 ]
Tenenbaum, Ariel [1 ,2 ]
Bello, Rachel [1 ,2 ]
机构
[1] Schneider Childrens Med Ctr Israel, Natl Ctr Childhood Diabet, Jesse Z & Sara Lea Shafer Inst Endocrinol & Diabe, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
来源
FRONTIERS IN ENDOCRINOLOGY | 2019年 / 10卷
关键词
cardiometabolic syndrome; children and adolescents; non-classical congenital adrenal hyperplasia; overweight; obesity; CONGENITAL ADRENAL-HYPERPLASIA; BODY-COMPOSITION; INSULIN-RESISTANCE; METABOLIC SYNDROME; PUBERTAL CHANGES; BLOOD-PRESSURE; ADOLESCENTS; INDEX; MASS; PATTERN;
D O I
10.3389/fendo.2019.00698
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Classical congenital adrenal hyperplasia is associated with an increased risk of obesity and cardiometabolic disease. The aim of the study was to determine if this is also true for non-classical congenital adrenal hyperplasia (NCCAH). Methods: A retrospective, cross-sectional, single-center study design was used. Data were collected on 114 patients (92 female) with NCCAH diagnosed during childhood/adolescence at a tertiary medical center. Patients were classified by treatment status at the last clinic visit. Outcome measures were assessed at diagnosis and the last clinic visit: weight status, body composition, blood pressure, lipid profile, and glucose metabolism. The prevalence of overweight/obesity was compared to the parental prevalence, and for patients aged 11-20 years, to the Israeli National Survey. Results: Mean age was 7.9 +/- 4.2 years at diagnosis and 17.1 +/- 6.9 years at the last follow-up. At the last clinic visit, 76 patients were under treatment with glucocorticoids, 27 were off-treatment (previously treated), and 11 had never been treated. The rate of obesity (11.4%) was similar to the parental rates, and the rate of overweight was significantly lower. In patients 11-20 years old, rates of obesity or obesity + overweight were similar to the general Israeli population (11.4 vs. 15.1%, P = 0.24 and 34.2 vs. 41.6% P = 0.18, respectively). No significant difference was found between glucocorticoid-treated and off-treatment patients in any of the metabolic or anthropometric parameters evaluated, except for a lower mean fat mass (% of body weight) in off-treatment patients (23.0 +/- 7.7% vs. 27.8 +/- 6.8%, P = 0.06). Systolic hypertension was found in 12.2% of NCCAH patients either treated or untreated. Conclusion: NCCAH diagnosed in childhood, whether treated or untreated, does not pose an increased risk of overweight, obesity, ormetabolic derangements in adolescence and early adulthood.
引用
收藏
页数:8
相关论文
共 41 条
  • [1] Cardio-metabolic risk factors in youth with classical 21-hydroxylase deficiency
    Ariyawatkul, Kansuda
    Tepmongkol, Supatporn
    Aroonparkmongkol, Suphab
    Sahakitrungruang, Taninee
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2017, 176 (04) : 537 - 545
  • [2] Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study
    Azziz, R
    Hincapie, LA
    Knochenhauer, ES
    Dewailly, D
    Fox, L
    Boots, LR
    [J]. FERTILITY AND STERILITY, 1999, 72 (05) : 915 - 925
  • [3] Association between Obesity and Parental Weight Status in Children and Adolescents
    Bahreynian, Maryam
    Qorbani, Mostafa
    Khaniabadi, Bita Moradi
    Motlagh, Mohammad Esmaeil
    Safari, Omid
    Asayesh, Hamid
    Kelishadi, Roya
    [J]. JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2017, 9 (02) : 111 - 117
  • [4] BMDP Statistical Software, 1993, BMDP STAT SOFTWARE
  • [5] High incidence of molecular defects of the CYP21 gene in patients with premature adrenarche
    Dacou-Voutetakis, C
    Dracopoulou, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (05) : 1570 - 1574
  • [6] Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349
  • [7] Abdominal adiposity and the polycystic ovary syndrome
    Escobar-Morreale, Hector F.
    Millan, Jose L. San
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2007, 18 (07) : 266 - 272
  • [8] Adult height of subjects with nonclassical 21-hydroxylase deficiency
    Eyal, Ori
    Tenenbaum-Rakover, Yardena
    Shalitin, Shlomit
    Israel, Shoshana
    Weintrob, Naomi
    [J]. ACTA PAEDIATRICA, 2013, 102 (04) : 419 - 423
  • [9] Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome
    Falhammar, Henrik
    Nordenstrom, Anna
    [J]. ENDOCRINE, 2015, 50 (01) : 32 - 50
  • [10] Clinical Characteristics of a Cohort of 244 Patients with Congenital Adrenal Hyperplasia
    Finkielstain, Gabriela P.
    Kim, Mimi S.
    Sinaii, Ninet
    Nishitani, Miki
    Van Ryzin, Carol
    Hill, Suvimol C.
    Reynolds, James C.
    Hanna, Reem M.
    Merke, Deborah P.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12) : 4429 - 4438